Anthony is one of Novartis’ champions who has been a great advocate for Novartis and patients, meeting with key members of state legislatures across the U.S.
He has gone above and beyond to educate policymakers about the importance of R&D and innovative therapies while highlighting the challenges and expenses of bringing new medicines to the market.